LS
BMY.RT

Leelyn Smith’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Leelyn Smith’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,295
Closed -$1K – 396
2020
Q4 		$1K Sell
1,295
-1,432
-53% -$3.05K ﹤0.01% 354
2020
Q3 		$6K Sell
2,727
-150
-5% -$428 ﹤0.01% 294
2020
Q2 		$10K Buy
2,877
+1,111
+63% +$4.01K ﹤0.01% 319
2020
Q1 		$7K Sell
1,766
-1,748
-50% -$5.76K ﹤0.01% 270
2019
Q4 		$11 Buy
+3,514
New +$9.14K 0.01% 260

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Leelyn Smith's BMY.RT Position: Q1 2021 in Review

Leelyn Smith sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 1,295 shares — an estimated $1K sold.

Leelyn Smith first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $10K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Leelyn Smith reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Leelyn Smith sold 1,295 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $1K.
  • Leelyn Smith first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Leelyn Smith's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $10K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Leelyn Smith's 13F filing for Q1 2021, filed 5 May 2021.